Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)
Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million…
Trust Stamp announces allowance by the United States Patent and Trademark Office (“USPTO”) of a Non-Provisional Patent Application in respect of technology designed to identify deep fake and other Generative AI fuelled attacks in identity authentication processes
Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture
Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer